Former GSK Exec Steven Skolsky Becomes Trimeris CEO
This article was originally published in The Pink Sheet Daily
Skolsky succeeds company founder Dani Bolognesi, who will stay on as chief scientific officer. Previously, Skolsky was GlaxoSmithKline senior VP-global commercial strategy.
You may also be interested in...
Trimeris is searching for a successor to President Nixon Ellis, PhD, following a June 2 announcement that he will leave the company by mutual agreement
Senior VP-Global Clinical & Pharmaceutical Development Elliott Sigal is acting president of Bristol-Myers Squibb’s research institute following the death of James Palmer.
The four-pronged plan will address “bio-burden,” manufacturing techniques, quality systems and execution, CEO Pien says. Chiron has met twice with U.K. authorities and hopes to realize similar progress with FDA soon.